Dianthus Therapeutics DNTH Payments for Capital Improvements

Payments for Capital Improvements at other companies

Churchill DownsCHDN

$19M+46.2%

RBC BearingsRBC

$17.7M+24.6%

AvalonBay CommunitiesAVB

$514K+101%

WelltowerWELL

$269.83M+12.3%

Realty IncomeO

$26.31M+14.9%

RHP

Ryman Hospitality PropertiesRHP

$18K-41.9%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForCapitalImprovements.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's payments for capital improvements.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's payments for capital improvements?: Dianthus Therapeutics (DNTH) reported payments for capital improvements of $10K in Q1 2026.
How has Dianthus Therapeutics's payments for capital improvements changed year-over-year?: Dianthus Therapeutics's payments for capital improvements decreased by 58.3% year-over-year, from $24K to $10K.